
李韶,女,博士,辽宁省兴辽计划领军人才/特聘教授,辽宁省教学名师,博士及硕士研究生导师。
辽宁省脑疾病神经保护与损伤修复重点实验室主任、辽宁省省级高校脑疾病研究重点实验室主任、辽宁省高校大连医科大学生理学黄大年式教师团队负责人、全国党建样板支部负责人、大连医科大学生理学教研室主任兼书记。
长期从事神经生理学研究,主持国家及省部级课题16项。近5年第一及通讯作者在Journal of cell biology,British Journal of Pharmacology,Cerebral Cortex, Aging Cell, Brain Behav Immun等杂志发表SCI文章30余篇,第一或主要完成人获教育部科技进步二等奖1项,辽宁省科技进步二等奖2项,三等奖2项,中华医学三等奖1项,辽宁省教学成果三等奖3项,获国内专利2项,国际专利4项,转化1项。
学习经历:
2004/09 - 2007/07,生理学博士,大连医科大学与新加坡国立大学联合培养
1989/09 - 1992/07,生理学系硕士,华中科技大学同济医学院
1982/09 - 1987/07,医疗系学士,滨州医学院
工作经历:
2000/09 - 至今, 教授、博士研究生导师,大连医科大学
2009/01 - 2009/05,Research Fellow,Department of Pharmacology, Yong Loo Lin School of Medicine, Centre for Life Sciences, National University of Singapore, Singapore,PI: Dr. Gavin S Dawe
2005/09 - 2008/07,Research Scientist,Institute of Molecular and Cellbiology, Department of Clinical Research, Singapore General Hospital, Singapore,PI: Zhicheng Xiao
1999/12 - 2000/08,高级访问学者,中国科学院上海生理所赵志奇教授研究组
1996/01 - 1996/12,高级访问学者,华中科技大学同济医学院实验医学中心李之望教授膜片钳实验室
1987/07 - 2000/07,助教、讲师、副教授,滨州医学院
研究方向:
神经退行性疾病发病机制及防治策略的研究
主要学术任职:
中国神经科学会神经内稳态与内分泌分会主任委员;
中国神经科学学会组织工作委员会委员;
中国神经科学会理事;
中国生理学会理事;
中国老年学和老年医学学会抗衰老分会理事;
辽宁省神经科学会副理事长;
大连市医学会第十届理事会常务理事;
大连市医学会生理学分会主任委员
承担项目(近5年):
1.辽宁省“兴辽英才计划”科技创新领军人才辽宁省特聘教授(XLYC1902044)2020.01-2022.12 100万,主持人。
2.2019年度辽宁省重点研发计划项目,蝎毒耐热合成肽抗帕金森病的临床前研究(2019020048-JH2/103),2019/05-2022/12, 30万,主持人。
3.国家科技部新药创制重大专项(2018ZX09301028-001),抗难治性癫痫I类新药蝎毒耐热肽的研发,332万,2018.01-2020.12,第2位。
4.辽宁省教育厅高等学校自然科学重点类项目(LZ2017001),抗难治性癫痫药蝎毒耐热肽临床前药代动力学研究 10万,2017.09-2020.08,主持人。
5.国家自然基金面上项目(81571061),Nav1.6在阿尔茨海默病神经网络异常中的作用及机制,2016.01-2019.12,57万,主持人。
6.国家自然基金面上项目(81371223),阿尔茨海默病郎飞结区Aβ生成及调控的分子机制研究,2014/01-2017/12,65万元,主持人。
7.国家自然基金重点项目(81230084/H27),情之所致糖尿病认知功能障碍的机理及滋补脾阴法防治的基础研究,2013/01-2017/12,180万,第3位。
代表性论文(近5年第一及通讯作者):
1.Reducing Nav1.6 expression attenuates the pathogenesis of Alzheimer's Disease by suppressing BACE1 transcription. Aging Cell. 2022 Mar 30;e13593.
2.TIP60 buffers acute stress response and depressive behaviour by controlling PPARγ-mediated transcription. Brain Behav Immun. 2022 Jan 31;101:410-422.
3.Two-hour acute restraint stress facilitates escape behavior and learning outcomes through the activation of the Cdk5/GR P S211 pathway in male mice. Experimental Neurology, 2022 2022 Feb 23;114023.
4.Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation. Front Pharmacol. 2021 Oct 4;12:704715.
5.Scorpion venom peptide SVHRSP ameliorates 6-OHDA induced neurotoxicity and neuroinflammation: potential role of Nav1.6 inhibition in microglia. British Journal of Pharmacology 2021 Apr 22. doi: 10.1111/bph.15502.
6.Scorpion Venom Heat-Resistant Peptide Attenuates Microglia Activation and Neuroinflammation. Frontiers in Pharmacology. 2021. In press
7.SRC-1 deficiency increases susceptibility of mice to depressive-like behavior after exposure to CUMS. Neurochemical Research, 2021 Jul;46(7):1830-1843.doi: 10.1007/s11064-021-03316-y.
8.Treatment with Bifidobacteria can suppress Aβ accumulation and neuroinflammation in APP/PS1 mice. Peer J 2020 Oct 28;8:e10262.
9.GPR50 Distribution in the Mouse Cortex and Hippocampus. Neurochemical Research, 2020 Oct;45(10):2312-2323.
10.SRC-1 Knockout Exerts No Effect on Amyloid β Deposition in APP/PS1 Mice. Frontiers in Aging Neuroscience,2020 Jun 17;12:145.
11.Reduction of NgR in perforant path decreases amyloid-β peptide production and ameliorates synaptic and cognitive deficits in APP/PS1 mice. Alzheimer's Research & Therapy 2020 Apr 24;12(1):47.
12.Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer’s Disease Model Mice. Journal of Alzheimer’s Disease 2020;75(1):245-260.
13.TRIM32 deficiency impairs synaptic plasticity by excitatory-inhibitory imbalance via notch pathway. Cerebral Cortex, 2020 August 2;30(8): 4617-4632.
14.NCAM regulates temporal specification of neuralprogenitor cells via profilin2 during corticogenesis. Journal of cell biology, 2020 Jan 6;219(1):e201902164.
15.Scorpion Venom Heat-resistant Peptide is Neuroprotective against Cerebral Ischemia-Reperfusion Injury associated with NMDA-MAPKs Pathway,Neuroscience Bulletin,2020 Mar;36(3):243-253.
16.Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease. Rev Neurosci. 2020 ; 31 (1): 77– 87.
17.The potential roles of dopamine in traumatic brain injury: a preclinical and clinical update Am J Transl Res 2019;11(5):2616-2631.
18.A research update on the anticancer effects of bufalin and its derivative. Oncology Letters, 2019 Apr;17(4):3635-3640.
19.Impaired cognitive function and altered hippocampal synaptic plasticity in mice lacking dermatan sulfotransferase Chst14/D4st1, Frontiers in Molecular Neuroscience,11 February 2019 doi: 10.3389/fnmol.2019.00026
20.Disrupted‐in‐schizophrenia‐1 protects synaptic plasticity in a transgenic mouse model of Alzheimer’s disease as a mitophagy receptor. Aging Cell, 2019 Feb;18(1):e12860.
21.Long-term social isolation inhibits autophagy activation, induces postsynaptic dysfunctions and impairs spatial memory. Experimental Neurology, 2018, Sep 13. pii: S0014-4886(18)30465-5.
22.Potential roles of exosomal microRNAs as diagnostic biomarkers and therapeutic application in Alzheimer’s disease. Neural Plasticity. 2017:7027380. doi: 10.1155/2017/7027380.
23.Aquaporin 4 in astrocytes is a target for therapy in Alzheimer's disease. Current Pharmaceutical Design. Current Pharmaceutical Design. 2017;23(33):4948-4957.
24.Effects of α2A Adrenoceptors on Norepinephrine Secretion from the Locus Coeruleus during Chronic Stress-Induced Depression. Frontiers in Neuroscience. 2017 May 1; 11: 243.
25.Amyloid precursor protein modulates Nav1.6 sodium channel currents through a Go-coupled JNK pathway. Scientific Reports ,2016 Dec 23; 6:39320,
26.The potential roles of aquaporin 4 in Alzheimer's disease. MOLECULAR NEUROBIOLOGY. 2016 Oct; 53(8):5300-9. doi: 10.1007/ s12035-015-9446-1. 2016 Oct 53(8):5300-9
27.Scorpion Venom Heat-Resistant Peptide Protects Transgenic Caenorhabditis elegans from β-Amyloid Toxicity. Front Pharmacol. 2016 Jul 26; 7: 227.
28.Brain-derived neurotrophic factor: a mediator of inflammation-associated. Rev Neurosci. 2016 Dec 1;27(8):793-811.
29.Elevated Neuronal Excitability Due to Modulation of the Voltage-Gated Sodium Channel Nav1.6 by Aβ1-42. Frontiers in Neuroscience, 2016, published: 09 March 2016 doi: 10.3389/fnins.2016.00094
30.Update on the effect of estradiol in postmenopause women with Alzheimer's disease: A systematic review. Acta Neurol Belg, 2016 Sep; 116(3): 249-57.
31.The neuroprotective effect of the association of aquaporin-4/glutamate transporter 1 (AQP4/GLT-1) against Alzheimer’s disease. Neural Plasticity. 2016 (2016), Article ID 4626593, 8 pages http://dx.doi.org/ 10.1155 /2016/ 4626593.
32.The research update on the potential roles of aquaporin 4 in neuroinflammation. Acta Neurol Belg, 2016 Jun;116(2):127-34
学术专著(近5年):
1.《生理学》主编 鲁有明 胡志安, 李韶编委,“十四五”普通高等教育本科规划教材,科学出版社 ISN 978-7-03-070811-3,出版时间:2022年1月第一版.
2.《生理学》,国家卫生健康委员会“十四五”规划教材,全国高等中医药教育教材,主编 郭建,杜联,李韶编委,2021年7月第四版,人民卫生出版社,ISBN978-117-31586-9
3.《基础医学与临床》,主编:郭益民,朱亮,参编:李韶,人民卫生出版社,2017,ISN 978-7-117-25095-5/R•25096
4.《Aquaporins》,主编:杨宝学,李韶参编,Springer出版社,2017,ISBN 978-94-024-1055-6.
5.《痴呆的中西医治疗》,主编:乐卫东,陈立典,李韶常务编委,科学出版社,2018,ISBN 97-7-03-058682-7
6.《医学观念的更新与启示》,主编:李树壮,朱亮;李韶编委。人民卫生出版社, 2018,ISBN:978-7-117-25746-6
科研获奖(近五年):
1.李韶(3/15)基于下尿量梗阻膀胱功能障碍的基础及临床研究与应用,辽宁省医学会,科技进步,三等奖 2019.10
2.李韶(3/15),基于纳米复合材料的干细胞神经损伤修复关键技术体系的创建和应用, 教育部,高等学校科学研究优秀成果奖(科学技术)科技进步,二等奖,2016,12
3.李韶(1/7),钠通道亚型Nav1.6与阿尔茨海默病发病机制相关性的基础与临床研究, 辽宁省科技进步,三等奖,2015,证书编号2015J-3-095-1
4.李韶(1/5),Nav1.6与阿尔茨海默病发病机制相关性及其干预靶点的研究,,辽宁省医学会,辽宁省医学会科技进步,三等奖,2015,证书编号2015-3-09-01
专利申请:
1.Modulation of Neural Activity and/or Condition. US Patent No. 60/841,6302008.03.06(Zhicheng Xiao, Quanhong Ma, Shao Li,Gavin S Davin)
2.METHODS OF REDUCING NEURONAL INJURY OR TOXICITY IN EPILEPSY, ALZHEIMER’S DISEASE OR PARKINSON’S DISEASE USING A SCORPION VENOM HEAT-RESISTANT SYNTHETIC PEPTIDE (SVHRSP), 2020-12-22, 美国, US 10,870,680 B2 (赵杰; 李韶; 张万琴)
2. 一种耐热合成肽及其用途,专利号:ZL2016 10645111.7(赵杰 李韶 张万琴)
3、サソリ毒耐熱合成ペプチド 日本发明专利JP 6483858,2019年 (赵杰,李韶,张万琴)
4、A SCORPION VENOM HEAT-RESISTANT SYNTHETIC PEPTIDE AND APPLICATIONS THEREOF,美国发明专利,US 15/800,802,2019年,(赵杰,李韶,张万琴)
5、a scorpion venom heat-resistant synthetic peptide and applications thereof,加拿大发明专利,CA 2,984,569,2019年,(赵杰,李韶,张万琴)
6、ADR1在缓解认知障碍中的应用 专利号2018102202773 2018年
(殷盛明 肖召扬 徐红 王冬梅 赵杰 李韶 孙艺平 于德钦 于志伟 薛莹)
联系方式:
Email: lishao89@hotmail.com; lishao89@dmu.edu.cn
办公电话:0411-86110352